The Covid-19 pandemic has caused delays in elective medical and surgical procedures in accordance with the measures and precautions to be taken. Alternative, low transmission risk procedures had to be adopted. Urgent and emergent interventional bronchoscopic procedures (IBP) were continued to be performed in life-threatening conditions. We aimed to evaluate the IBP performed during the ongoing pandemic in terms of patient selection, diagnoses, emergency/urgency, type of procedure used, success, and complications.Methods: Patients who underwent IBP in the first wave of pandemic between March 11, 2020, when the first patient was diagnosed with Covid-19, and June 1, 2020, in Turkey.Results: Twenty-one patients with a mean age of 54.7±17 years underwent 23 emergent/ urgent IBP. Nine patients had malignant and 9 had benign airway obstruction. The remaining 3 patients were diagnosed with hemoptysis and pulmonary alveolar proteinosis.The success rate of IBP treatment was 100%, the acute complication rate was 4.7%, the chronic complication rate was 4.7%, the procedural mortality was 0.0% and the 30-days early mortality rate was 9%. All procedures were performed in interventional pulmonology (IP) unit with negative room pressure with as few auxiliary staff as possible. None of our team members developed signs and symptoms of coronavirus disease with the contribution of the constantly updated literature to our increasing clinical experience and measures taken.
Conclusion:IBP can be performed with high success and low complication rates, even under pandemic conditions, especially in emergent/urgent life-threatening situations such as central airway obstructions, massive hemoptysis, and other diseases, in the absence of other surgical and invasive procedures. They have a life-saving, survival-prolonging and time-saving role up to primary therapy, provided that all necessary precautions are taken.